Washington University School of Medicine Receives Fetal Bovine Serum Donation from Peak Serum, Inc.
TOGETHER, WE IMPACT LIVES.
Peak Serum, Inc. is proud to announce its 2018 Cares for Cures Grant recipient, Russell Pachynski of the Washington University School of Medicine.
The Cares for Cures Grant was born from Peak Serum’s mission to support research to cure diseases through the donation of Fetal Bovine Serum. Research labs and organizations are encouraged to apply for donations of Fetal Bovine Serum through the Peak Serum website and grants are given each fiscal year.
Pachynski, Assistant Professor at Washington University School of Medicine, is the second recipient of the Cares for Cures Grant. His team focuses broadly on the leukocyte migration (or trafficking) in the setting of tumor immunology. “My lab is thrilled to continue our research with the help of Peak Serum’s Cares for Cures Grant,” said Pachynski. “We are so thankful for the support of our research efforts to make breakthroughs each and every day.”
Click Here to learn more about Dr. Pachynski’s research and lab.
“Dr. Pachynski’s lab is the epitome of what the Cares for Cures Grant stands for. This grant aids, acknowledges and encourages researchers to make strides to fight diseases,” said Tom Kutrubes, Peak Serum President and CEO. “We are proud to be able to assist this research lab and continue motivating labs worldwide to carry out cutting-edge research.”
Peak Serum launched Cares for Cures in 2017 and that same year awarded Dr. Wendy Huang of the UC San Diego School of Medicine for her work in examining the link between DDX proteins, their ability to modify RNA structures and their link between inflammation and cancers.
Peak Serum, Inc. Accepting Applications for Fetal Bovine Serum Donation to Support Disease Curing Research
Through the Cares for Cures Grant, Peak Serum, Inc. aims to provide Fetal Bovine Serum product donations to research labs working to cure diseases worldwide. Researchers seeking support from the grant may apply directly.
“The mission behind the Cares for Cures Grant is to aid, acknowledge and encourage researchers making strides to fight diseases,” said Tom Kutrubes, Peak Serum President and CEO. “Through the donation, we hope to motivate labs worldwide to continue carrying out research.”
Dr. Wendy Huang of the UC San Diego School of Medicine was awarded the first Cares for Cures Grant in 2017. Her team’s research impacts inflammatory bowel conditions, breast, prostate and intestinal cancers and other inflammation-related diseases. “It is researchers like Dr. Huang who make the breakthroughs that guide tomorrow’s treatments. Peak Serum is happy to support her efforts.”
Peak Serum, Inc. Continues Support of Bioscience Industry Through Colorado Business Association (CBSA) Membership Renewal
Peak Serum, Inc. uses CBSA and European Serum Products Association memberships to establish relationships, engage research and educate others in the industry.
Peak Serum, Inc., announces their third-year membership renewal with Colorado Bioscience Association, (CBSA). Peak Serum, Inc. continues to support the biosciences with a hope to impact and improve the industry alongside other CBSA members.
“As leaders in bioscience research, development and manufacturing, the members of Colorado Bioscience Association’s united goal is to ensure valuable connections and opportunities to assist in Colorado’s business growth and innovating economy,” said Tom Kutrubes, President and CEO of Peak Serum. “Peak Serum, Inc. is proud to be apart of such a diverse and forward-thinking group. We look forward to many years of membership and growth with CBSA.”
The key benefits of CBSA membership are designed to support members through business networking events, advocacy on behalf of the industry to elected officials, bottom line savings through purchasing programs and knowledge-sharing programs.
An esteemed Board of Directors made from Colorado’s top bioscience leaders lead CBSA and work alongside an accomplished group of members including Colorado State University, Bio2 Medical, Silvergate Pharmaceuticals and AlloSource. For more information about CBSA, visit cobioscience.com
To emphasize the importance of the bioscience industry, Peak Serum donates Fetal Bovine Serum (FBS) to research projects through its Cares for Cures initiative. “Researchers are making enormous strides in fighting disease and curing afflictions, and Cares for Cures wants to acknowledge and encourage that work,” said Kutrubes “Biomedical research eventually enriches humanity. Our product donation will hopefully allow more labs to perform more research for years to come.”
Researchers seeking support from Cares For Cures may apply directly to the program here.
Peak Serum’s Fetal Bovine Serum Receives Credit in Leading Cancer Journal, Oncogene
Peak Serum is proud to announce its assistance in cancer research at The Scripps Research Institute. Peak Serum’s Fetal Bovine Serum was recently credited in one of the world’s leading cancer journals, Oncogene. In this publication, LTBP3 promotes early metastatic events during cancer cell dissemination, human tumor cell lines and culture conditions were routinely cultured in DMEM supplemented with 10% of Peak Serum’s Fetal Bovine Serum.
“Peak Serum is honored to be mentioned by The Scripps Research Institute in such a notable and impressive cancer journal, Oncogene,” says Tom Kutrubes, President, and CEO of Peak Serum. “We hope to continue helping researchers publish their work around the world.”
The Scripps Research Institute is a world leader in biomedical research – expanding the frontiers of knowledge, accelerating new treatments for disease and training the next generation of scientists in this critical work. This institute one of the world’s largest, private, non-profit research organizations — stands at the forefront of basic biomedical science, a vital segment of medical research that seeks to comprehend the most fundamental processes of life. For more information, click here.
About Oncogene
Oncogeneaims to make substantial advances that contribute to cancer by publishing outstanding research. Areas covered by Oncogeneinclude, but are not limited to, the cellular and molecular biology of cancer including resistance to cancer therapies, and development of better approaches to improving survival. Across cancer biology, this publication has a broad remit encompassing the life sciences and biomedicine, from the most fundamental and theoretical work, through to translational, applied, and clinical research. Reviewing Editors are among the most respected and accomplished individuals in their fields – from genetics and structural biology, to function and mechanism. Visit https://www.nature.com/onc for more information.
European Serum Products Association Grants Membership to Peak Serum, Inc.
Peak Serum is excited to announce it is officially a member of the European Serum Products Association (ESPA) as ofJuly 1, 2017.
“The purpose of ESPA is to connect professional companies of the animal serum processing industry in the European Union and in other European and Non-European countries to the interests of its members,” said Tom Kutrubes, President, and CEO of Peak Serum. “We are honored that we meet the necessary requirements in order to be accepted as a member of an organization that is consistently and effectively improving the serum industry and ethical standards”
ESPA Objectives :
to study questions relating to and defending the interests of the European Serum
Processing Industry;
to represent its Members with the Commission of the European Communities, with
other European institutions and with other national and international organizations,
whether in the private or the public sector
to promote the harmonization of regulations covering the trade and the use of animal
serum, following international standards set by the World Animal Health Organization
OIE and the World Health Organization (WHO).
promote the education of Members, regulatory authorities and the serum industry
stakeholders in general.
to consolidate the confraternal ties between all of its Members;
to permit the exchange of professional and technical information within the industry
itself but also with all economic and scientific sectors;
ensuring that the market for serum products operates in compliance with the
European Union (EU) rules and with any international rules such as the ones from the
World Organisation for Animal Health (OIE); and
to do anything which is, in the widest sense of the word, connected with or may be
conducive to the attainment of these objectives.
The European Serum Products Association became active in May of 2017 ensuring the market for serum products operates in compliance with the European Union rules and international rules.
Peak Serum, Inc. Receives USDA/APHIS/VS Approval to Supply Fetal Bovine Serum to European Union
Peak Serum, Inc. was inspected by the United States Department of Agriculture (USDA) and approved by the Animal and Plant Health Inspection Service (APHIS) and Veterinary Services (VS) for compliance with Regulation (EC) 1069/2009. This approval allows Peak Serum, Inc. to directly export Fetal Bovine Serum to the EU and supply US facilities for eventual export to the EU.
“The fetal bovine serum Peak Serum supplies for life science and diagnostics are carefully selected to meet the standards set for reliability, applicability, quality and innovation,” Tom Kutrubes, Peak Serum President said. “We are thrilled to have the opportunity to now provide Fetal Bovine Serum products to the European Union. Our continuous efforts to improve our high standard of quality and support is part of our internal quality system and we look forward to continued growth and expansion into new markets.”
In order to retain this approval, Peak Serum, Inc. must continue to operate under Regulation (EC) 1069/2009 and all notarized forms provided during the approval process. The facility is subject to unannounced compliance inspections throughout the year to verify this continued compliance.
APHIS is an agency of USDA’s Marketing and Regulatory Programs.
Peak Serum Expands to Larger Facility in Wellington
Peak Serum, a supplier of fetal bovine serum to bioscience researchers, moves operations from Fort Collins to a larger location in Wellington.
Tom Kutrubes, president of Peak Serum, leads the Peak Serum move to a 3,000-square-foot building at 6598 Buttercup Drive in the Wellington Business Center. The facility allows Peak Serum to maximize efficiency and product flow, Kutrubes said.
The facility has a temperature-monitored cold-storage unit with the capacity to store 12,000 liters of serum. The new plant also features energy-saving systems and equipment.
Peak Serum contracts with third-parties to extract and process the serum. The serum ships to Wellington for storage before distribution to Peak Serum’s clients.
Biotech researchers use fetal bovine serum because its variety of proteins maintain cultured cells in a medium in which they can survive, grow and divide.
“Researchers’ focus should be on their work, not worrying about reliably securing the media they need to perform,” Kutrubes said. “Our move to a new location allows us to continue to provide FBS to research facilities across the country.”
Peak Serum sells 500 milliliters of the serum for about $450, according to its website.
Peak Serum Sponsors Colorado “Strides for CJD” Event
Peak Serum Proudly Supports the Fight Against Creutzfeldt-Jakob Disease
Peak Serum announced it will be an official sponsor of this year’s Strides for CJD event in Fort Collins on Oct. 1.
The contribution helps the Creutzfeldt-Jakob Disease Foundation continue to fund research and the fight against the degenerative brain disorder, and enables the organization to stage its annual fundraising event, to be held 10 a.m.Oct. 1 at the Colorado State University Oval.
“There’s currently no cure or treatment for patients with CJD,” Tom Kutrubes, President and Founder of Peak Serum said. “Peak Serum’s support of the event enables the foundation to continue to better the lives of the people who suffer from this debilitating disease.”
CJD is caused by “prions,” proteins which misfold in the brain, with devastating effects, including rapid mental and physical deterioration. CJD is the most common of the “prion diseases.” Two others, FFI (Fatal Familial Insomnia) and GSS (Gerstmann-Straussler-Scheinker Disease), are typically hereditary and have a slightly different progression. Prion diseases are invariably fatal.
“We were so impressed by what the families of the CJD Foundation achieved in 2015, the first year of Strides for CJD,” said Debbie Yobs, CJD Foundation President. “More than a thousand people around the U.S. joined us last year to stride for a cure, including several hundred in New Jersey. The funds they raised provided vital support for our HelpLine, family support, medical education, and research programs. Participants in Strides for CJD also raise awareness of prion diseases like CJD in their communities and through social media,” she added.
On-site registration begins at 9:15, and after the one-mile walk, families may enjoy games and other activities. Parking is available at CSU’s lot 310 or 315. For more information about the Strides for CJD, visit www.strides4cjd.com/colorado-event
About CJD and Prion Diseases: Prion diseases are a group of rare, invariably fatal brain disorders. The best known of the prion diseases is Creutzfeldt-Jakob Disease (CJD). CJD can impair memory, coordination, and vision, and causes mental and physical deterioration. There are no treatments and no cures. Two other prion diseases are called FFI (Fatal Familial Insomnia) and GSS (Gerstmann-Straussler-Scheinker Disease). Those are typically hereditary and have a slightly different progression.
About the CJD Foundation: The CJD Foundation provides support for families affected by prion disease. Programs include a seven-day HelpLine, referrals and caregiving information, family workshops, and support groups, as well as medical education and an annual conference for families and scientists. For more information, call 800‑659-1991 or help@cjdfoundation.org.
Peak Serum Announces Membership to BioFlorida
Peak Serum, Inc. is proud to announce its recent membership to BioFlorida, the voice of Florida’s life sciences industry.
BioFlorida represents nearly 5,500 establishments and research organizations ranging from emerging and established life science companies to universities, research institutions, hospitals, medical centers, investors and service providers.
“As Peak Serum continues to grow and expand nationally, we’re strategically aligning with proactive industry associations,” said Tom Kutrubes, President and CEO of Peak Serum. “Florida’s bioscience industry is developing breakthrough discoveries and therapies that have the ability to propel the industry and improve the quality of life across the country and around the world. Peak Serum is looking forward to collaborating with industry leaders and being a life sciences change agent.”
Peak Serum, Inc. is a privately owned and independent supplier of life science laboratory products with a core focus on Fetal Bovine Serum (FBS) for cGMP / clinical trial research and diagnostics applications.
Peak Serum, Inc. is proud to announce its recent membership to Georgia Bio (GaBio), joining esteemed members such as The University of Georgia, Johnson & Johnson, Emory University and Sutherland.
Georgia Bio is a non-profit, membership-based organization that promotes the interests and growth of the life sciences industry.
In an effort to advance the growth of Georgia’s life sciences industry, GaBio conducts business and economic development activities; advocates on public policy matters; educates the public about the benefits of life science research and provides a thriving network for the exchange of ideas, information and opportunities.
“Georgia Bio was a logical and natural fit for Peak Serum based on their goals to improve the state of the environment, expand the number of technology jobs and enhance student achievement in science education. Peak Serum is looking forward to being a part of this coalition to create a healthier world,” said Tom Kutrubes, President and CEO of Peak Serum.
Peak Serum, Inc. is a privately owned and independent supplier of life science laboratory products with a core focus on Fetal Bovine Serum (FBS) for cGMP / clinical trial research and diagnostics applications.
Peak Serum offers a wide range of high quality, 100% US origin and USDA-approved FBS products for all levels of research compliance. Peak Serum’s products are backed with superior knowledge, while delivering competitive market pricing and a consistent, readily available supply.
“We have used several brands of serum in our laboratory, but only use Peak Serum now,” said Laura Chubb on behalf of Colorado State University Flint Animal Cancer Center. “The improvement we have seen with Peak Serum is in the proliferation rate of our mesenchymal stem cells, it has been much improved over other serum brands.”
